Merck KGaA (MKKGY) Earnings Date, Estimates & Call Transcripts $29.15 -0.15 (-0.51%) As of 03:59 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort Interest Merck KGaA Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 21Before Market OpensEstimatedActual EPS (Mar. 6) $0.54 Beat By $0.07 Consensus EPS (Mar. 6) $0.47 Merck KGaA issued Q4 2024 earnings on March 6, 2025, reporting an EPS of $0.54, which topped the consensus estimate of $0.47 by $0.07. Quarterly revenue was reported to be $5.78 billion, above analysts' expectations of $5.40 billion. With a trailing EPS of $1.87 and a P/E Ratio of 17.99, Merck KGaA's earnings are expected to grow 9.63% next year, from $1.87 to $2.05 per share. MKKGY Upcoming EarningsMerck KGaA's next earnings date is estimated for Wednesday, May 21, 2025, based off prior year's reporting schedules. Get Merck KGaA Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck KGaA and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMKKGY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MKKGY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Merck KGaA Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$1.87 EPSNext Year EPS Consensus Estimate: $2.05 EPS Remove Ads Merck KGaA Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/21/2025(Estimated)-------3/6/2025Q4 2024$0.47$0.54+$0.07$0.54$5.40B$5.78B8/1/2024Q2 2024-$0.30+$0.30$0.30-$5.76B5/15/2024Q1 2024$0.38$0.35 -$0.03$0.35-$5.56B3/7/2024Q4 2023$0.43$0.40 -$0.03$0.51$5.58B$5.63B11/9/2023Q3 2023-$0.37+$0.37$0.37-$5.63B8/3/2023Q2 2023-$0.48+$0.48$0.61-$5.78B5/10/2023Q1 2023-$0.39+$0.39$0.39-$5.68B Merck KGaA Earnings - Frequently Asked Questions When is Merck KGaA's earnings date? Merck KGaA has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 21st, 2025 based off last year's report dates. Learn more on MKKGY's earnings history. Did Merck KGaA beat their earnings estimates last quarter? In the previous quarter, Merck KGaA (OTCMKTS:MKKGY) reported $0.54 earnings per share (EPS) to beat the analysts' consensus estimate of $0.47 by $0.07. Learn more on analysts' earnings estimate vs. MKKGY's actual earnings. How much revenue does Merck KGaA generate each year? Merck KGaA (OTCMKTS:MKKGY) has a recorded annual revenue of $22.72 billion. How much profit does Merck KGaA generate each year? Merck KGaA (OTCMKTS:MKKGY) has a recorded net income of $3.06 billion. MKKGY has generated $1.87 earnings per share over the last four quarters. What is Merck KGaA's price-to-earnings ratio? Merck KGaA (OTCMKTS:MKKGY) has a trailing price-to-earnings ratio of 17.99 and a forward price-to-earnings ratio of 15.59. The price/earnings-to-growth ratio is 2.05. What is Merck KGaA's EPS forecast for next year? Merck KGaA's earnings are expected to grow from $1.87 per share to $2.05 per share in the next year, which is a 9.63% increase. More Earnings Resources from MarketBeat Related Companies Regeneron Pharmaceuticals Earnings Takeda Pharmaceutical Earnings Alnylam Pharmaceuticals Earnings Beigene Earnings Bayer Aktiengesellschaft Earnings Royalty Pharma Earnings Merck KGaA Earnings Teva Pharmaceutical Industries Earnings Astellas Pharma Earnings Genmab A/S Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles These 3 Q1 Earnings Winners Will Go HigherAnalysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before Earnings Remove Ads This page (OTCMKTS:MKKGY) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | SponsoredMagnificent 7 wipeout: What's next?A massive wave of volatility is sweeping the stock market... After the recent selloff, the "Magnificent Sev...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MKKGY Stock Alerts